Duratek, along with its joint venture partners, was awarded a contract that with all options exercised would total about $128 million. The contract, awarded by the U.S. Department of Energy (DOE), calls for the down-blending and extraction of isotopes from enriched uranium-233 (U-233). The cost-plus fixed fee contract is estimated to cover a nine-year period in a three-phased approach. DOE has more than 1,200 containers of the material at the Oak Ridge National Laboratory (ORNL). Down-blending and stabilizing this material will save costly monitoring and security protocols, place the U-233 in a safe and stable configuration, and make thorium (Th229) available to produce actinium (Ac225) for cancer research and treatment. The joint venture, named Isotek Systems, consists of three members: Duratek; Nuclear Fuel Services, Inc. (NFS); and Burns and Roe Enterprises, Inc. Duratek’s portion of the joint venture is 45 percent, and its primary role is overall project and business management, processing facility operations, project safety and compliance, commercialization of Ac-225 , and safe shutdown of the storage facility. NFS’ primary role is down-blending, thorium extraction, process design, ES&H, safeguards and security, and nuclear materials control and accountability. Burns and Roe’s primary role is project controls and reporting, facility design modifications, engineering drawings, and construction management. Commercial partners will work with Isotek to produce and deliver the isotopes which show promise in the treatment of several types of cancer.